- Laws of Fiji

[MP 12,485] SCHEDULE 5 (Regulation 7)HAZARDOUS POISONS

Abamectin—
(a)in preparations, for internal use for the treatment of animals, containing 1 per cent or less of abamectin; or
(b)in gel formulations containing 0.05 per cent or less of abamectin in applicators containing 50 mg or less of abamectin.
Abscisic acid.
Acequinocyl.
Acetic acid (excluding its salts and derivatives) in preparations containing more than 30 per cent of acetic acid (CH₃COOH) except—
(a)when included in schedules 2 or 6; or
(b)for therapeutic use.
Acetone except in preparations containing 25 per cent or less of designated solvents.
Acriflavinium chloride in preparations for veterinary use containing 2.5 per cent or less of acriflavinium chloride.
Afoxolaner in oral divided preparations each containing 150 mg or less of afoxolaner per dosage unit—
(a)for the treatment and prevention of flea infestations and control of ticks in dogs; or
(b)for the treatment and prevention of flea infestations, control of ticks, gastrointestinal nematodes and heartworm in dogs, when combined with milbemycin oxime.
Aklomide.
Albendazole for the treatment of animals, in preparations containing 12.5 per cent or less of albendazole except in intraruminal implants each containing 3.85 g or less of albendazole.
Alkaline salts, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination—
(a)in solid orthodontic device cleaning preparations, the pH of which as an “in-use” aqueous solution is more than 11.5;
(b)in solid automatic dishwashing preparations, the pH of which in a 500 g/l aqueous solution or mixture is more than 11.5 but less than or equal to 12.5;
(c)in other solid preparations, the pH of which in a 10 g/l aqueous solution is more than 11.5; or
(d)in liquid or semi-solid preparations, the pH of which is more than 11.5, unless—
(i)in food additive preparations for domestic use; or
(ii)in automatic dish washing preparations for domestic use with a pH of more than 12.5,
except when separately specified in the schedules to these Regulations.
Alkoxylated fatty alkylamine polymer in preparations containing 50 per cent or less of alkoxylated fatty alkylamine polymer except in preparations containing 20 per cent or less of alkoxylated fatty alkylamine polymer.
Allethrin in preparations containing 10 per cent or less of allethrin except—
(a)in insecticidal mats; or
(b)in other preparations containing 1 per cent or less of allethrin.
Alloxydim.
Alpha-cypermethrin—
(a)in aqueous preparations containing 3 per cent or less of alpha-cypermethrin; or
(b)in other preparations containing 1.5 per cent or less of alpha-cypermethrin.
Ametryn.
Amines for use as curing agents for epoxy resins except when separately specified in the schedules to these Regulations.
Aminoacridine in preparations for veterinary use containing 2.5 per cent or less of aminoacridine.
Aminopyralid in preparations containing 22 per cent or less of aminopyralid.
Amitrole.
Aminocyclopyrachlor.
Amisulbrom.
Ammonia (excluding its salts and derivatives other than ammonium hydroxide) in preparations containing 5 per cent or less of ammonia except—
(a)in preparations for human internal therapeutic use;
(b)in preparations for inhalation when absorbed in an inert solid material; or
(c)in preparations containing 0.5 per cent or less of free ammonia.
Ammonium thiocyanate except in preparations containing 10 per cent or less of ammonium thiocyanate.
Anhydrides, organic acid for use as curing agents for epoxy resins except when separately specified in the schedules to these Regulations.
Anise oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 50 per cent or less of anise oil.
Aspirin for the treatment of animals, in divided preparations when packed in blister or strip packaging or in a container with a child-resistant closure.
Atrazine.
Azadirachta indica extracts (neem extracts), extracted from neem seed kernels using water, methanol or ethanol, in preparations containing 5 per cent or less of total limonoids, for agricultural use.
Azoxystrobin.
Bacillus thuringiensis delta endotoxin encapsulated in killed pseudomonas fluorescens.
Barium silicofluoride when coated on paper in an amount not exceeding 8 mg of barium silicofluoride per sq. cm.
Basil oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 5 per cent or less of methyl chavicol.
Beauveria bassiana in preparations containing 1 x 10⁸ Colony Forming Units (CFU)/ml or less of beauveria bassiana.
Benalaxyl.
Bendiocarb in preparations containing 2 per cent or less of bendiocarb.
Bentazone.
Benzalkonium chloride in preparations containing 10 per cent or less of benzalkonium chloride except in preparations containing 5 per cent or less of benzalkonium chloride.
Benzofenap.
Benzoyl peroxide except—
(a)when included in schedules 2 or 4; or
(b)in preparations containing 5 per cent or less of benzoyl peroxide.
Bergamot oil except—
(a)when steam distilled or rectified;
(b)in preparations for internal use;
(c)in preparations containing 0.4 per cent or less of bergamot oil;
(d)in soaps or bath or shower gels that are washed off the skin;
(e)in medicines for human therapeutic use when compliant with the labelling requirements under the Act; or
(f)in other preparations when packed in containers labelled with the statement “Application to the skin may increase sensitivity to sunlight”.
Betacyfluthrin—
(a)in aqueous preparations containing 2.5 per cent or less of betacyfluthrin; or
(b)in solid preparations containing 8 per cent or less of betacyfluthrin in a plastic matrix.
Bicyclopyrone in preparations containing 20 per cent or less of bicyclopyrone.
Bifluorides (including ammonium, potassium and sodium salts), in preparations containing 0.3 per cent or less of total bifluorides.
Bioallethrin in preparations containing 10 per cent or less of bioallethrin except in preparations containing 1 per cent or less of bioallethrin.
Bioresmethrin except in preparations containing 10 per cent or less of bioresmethrin.
Bispyribac except in preparations containing 10 per cent or less of bispyribac.
Bixafen.
Boric acid (excluding its salts) and borax except—
(a)when included in Schedule 4;
(b)in preparations, other than insect baits, containing 1 per cent or less of boron; or
(c)in hand cleaning preparations.
Boron trifluoride in preparations containing 0.1 per cent or less of boron trifluoride (BF₃).
Broflanilide in preparations containing 0.3 per cent or less of broflanilide.
Bromuconazole in preparations containing 20 per cent or less of bromuconazole.
Bupivacaine in aqueous gel preparations containing 0.5 per cent or less of bupivacaine, for the dermal spray-on administration to post-surgical wounds associated with ‘mulesing’ of sheep; tail docking and castration of lambs; or castration and disbudding/dehorning in calves.
Buprofezin except in preparations containing 40 per cent or less of buprofezin.
Buthidazole.
Butoxycarboxim in solid preparations containing 10 per cent or less of butoxycarboxim.
Butralin.
Butroxydim.
n-butyl alcohol in preparations containing 10 per cent or less of n-butyl alcohol except—
(a)in preparations containing 5 per cent or less of n-butyl alcohol; or
(b)in preparations for cosmetic or therapeutic use other than spray form.
Camphor as a natural component in essential oils containing 10 per cent or less of camphor except—
(a)in medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert, and labelled with the warnings “KEEP OUT OF REACH OF CHILDREN” and “NOT TO BE TAKEN”;
(c)in rosemary oil, sage oil (Spanish), or lavandin oils; or
(d)in preparations containing 2.5 per cent or less of camphor.
Carbamide peroxide in preparations containing 18 per cent or less of carbamide peroxide except in preparations containing 9 per cent or less of carbamide peroxide.
Carbaryl—
(a)in preparations containing 10 per cent or less of carbaryl except when included in Schedule 4; or
(b)when impregnated into plastic resin material containing 20 per cent or less of carbaryl.
Cassia oil except—
(a)in food additives;
(b)in preparations for dermal use as a rubefacient containing 5 per cent or less of cassia oil; or
(c)in other preparations containing 2 per cent or less of cassia oil.
Chlorfenac.
Chlorfenapyr in preparations containing 0.5 per cent or less of chlorfenapyr.
Chlorfenson.
Chlorhexidine in preparations containing 3 per cent or less of chlorhexidine except—
(a)in preparations containing 1 per cent or less of chlorhexidine; or
(b)when in solid preparations.
Chlorinating compounds containing 20 per cent or less of available chlorine, except—
(a)when separately specified in the schedules to these Regulations;
(b)sodium hypochlorite preparations with a pH of less than 11.5;
(c)liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statement “WARNING — Ensure adequate ventilation when using. Vapour may be harmful. May give off dangerous gas if mixed with other products”;
(d)liquid preparations containing less than 2 per cent of available chlorine; or
(e)other preparations containing 4 per cent or less of available chlorine.
Chlornidine.
Chlorocresol except in preparations containing 3 per cent or less of chlorocresol.
Chlorpropham.
Chlorpyrifos—
(a)in aqueous preparations containing 20 per cent or less of microencapsulated chlorpyrifos;
(b)in controlled release granular preparations containing 10 per cent or less of chlorpyrifos; or
(c)in other preparations containing 5 per cent or less of chlorpyrifos,
except in prepared potting or soil mixes containing 100 g or less of chlorpyrifos per cubic metre.
Chlorsulfuron.
Chlortetracycline in preparations—
(a)for topical application to animals for ocular use only; or
(b)containing 40 per cent or less of chlortetracycline, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Chlorthal-dimethyl.
Cinmethylin.
Cinnamon bark oil except—
(a)in food additives; or
(b)in preparations containing 2 per cent or less of cinnamon bark oil.
Clethodim.
Climbazole in preparations containing 40 per cent or less of climbazole except—
(a)in leave-on hair, face and foot cosmetic preparations containing 0.5 per cent or less of climbazole; or
(b)in other preparations (that are not leave-on cosmetic preparations) containing 2 per cent or less of climbazole.
Clofentezine.
Clopyralid.
Cloquintocet.
Clorsulon.
Clothianidin in preparations containing 20 per cent or less of clothianidin except in gel preparations dispensed in sealed cartridges containing 1 per cent or less of clothianidin.
Clove oil for topical use in the mouth in a pack containing 5 ml or less of clove oil except in preparations containing 25 per cent or less of clove oil.
Copper acetate in preparations containing 20 per cent or less of copper acetate except in preparations containing 5 per cent or less of copper acetate.
Copper compounds in animal feed additives containing 5 per cent or less of copper except in preparations containing 1 per cent or less of copper.
Copper hydroxide in preparations containing 50 per cent or less of copper hydroxide except in preparations containing 12.5 per cent or less of copper hydroxide.
Copper oxides in preparations containing 25 per cent or less of copper oxides except—
(a)in preparations for internal use;
(b)in marine paints; or
(c)in other preparations containing 5 per cent or less of copper oxides.
Copper oxychloride in preparations containing 50 per cent or less of copper oxychloride except in preparations containing 12.5 per cent or less of copper oxychloride.
Copper sulfate in preparations containing 15 per cent or less of copper sulfate except—
(a)in preparations for internal use; or
(b)in other preparations containing 5 per cent or less of copper sulfate.
Coumatetralyl in rodenticides containing 0.05 per cent or less of coumatetralyl.
4-cpa.
Cyanatryn.
Cyanoacrylate esters in contact adhesives except—
(a)when labelled with the warning—
“KEEP OUT OF REACH OF CHILDREN. Avoid contact with skin and eyes and avoid breathing vapour. Bonds on contact. Should fingers stick together apply a solvent such as acetone to contact areas then wash off with water. Do not use solvents near eyes or open wounds. In case of eye contact immediately flush with water”; or
(b)when packed in sealed measure packs each containing 0.5 g or less of cyanoacrylate esters—
(i)labelled with the approved name or trade name of the poison, the quantity and the warning “Can cause eye injury. Instantly bonds skin”; and
(ii)enclosed in a primary pack labelled with the warning—
“KEEP OUT OF REACH OF CHILDREN. Avoid contact with skin and eyes and avoid breathing vapour. Bonds on contact. Should fingers stick together apply a solvent such as acetone to contact areas then wash off with water. Do not use solvents near eyes or open wounds. In case of eye contact immediately flush with water”.
Cyantraniliprole.
Cyanuric acid (excluding its salts and derivatives).
Cyazofamid.
Cyclohexanone peroxide.
Cycloprothrin except in preparations containing 10 per cent or less of cycloprothrin.
Cycloxydim.
Cyflufenamid.
Cyfluthrin—
(a)in wettable powders containing 10 per cent or less of cyfluthrin;
(b)in emulsifiable concentrates containing 2 per cent or less of cyfluthrin; or
(c)in emulsions containing 5 per cent or less of cyfluthrin.
Cyhalofop-butyl.
Cymiazole.
Cypermethrin in preparations containing 10 per cent or less of cypermethrin.
Cyphenothrin in preparations containing 10 per cent or less of cyphenothrin.
Cyproconazole except in preparations containing 10 per cent or less of cyproconazole.
Cyprodinil.
Cythioate for the treatment of animals—
(a)in divided preparations containing 30 mg or less of cythioate per dosage unit when packed in blister or strip packaging or in a container with a child-resistant closure; or
(b)in undivided preparations containing 5 per cent or less of cythioate.
2,4-D in preparations containing 20 per cent or less of 2,4-D.
Daminozide.
2,4-DB.
Decoquinate.
Deltamethrin—
(a)when impregnated in plastic resin strip material containing 4 per cent or less of deltamethrin;
(b)in aqueous preparations containing 5 per cent or less of deltamethrin when no organic solvent other than a glycol is present;
(c)in wettable granular preparations containing 25 per cent or less of deltamethrin when packed in child-resistant packaging each containing 3 g or less of the formulation;
(d)in water-dispersible tablets each containing 500 mg or less of deltamethrin in child-resistant packaging; or
(e)in other preparations containing 0.5 per cent or less of deltamethrin,
except—
(i)in factory prepared mosquito nets containing 1 per cent or less deltamethrin; or
(ii)in preparations containing 0.1 per cent or less of deltamethrin.
Dembrexine in oral preparations for the treatment of animals.
2,4-des.
Diafenthiuron.
N,n-diallyldichloroacetamide except in preparations containing 10 per cent or less of n,n-diallyldichloroacetamide.
Diazinon in dust preparations containing 2 per cent or less of diazinon.
Dicamba (including its salts and derivatives) in preparations containing 20 per cent or less of dicamba.
Dichlone.
P-dichlorobenzene.
Dichloroisocyanuric acid containing 40 per cent or less of available chlorine, except in—
(a)liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statement “WARNING — Ensure adequate ventilation when using. Vapour may be harmful. May give off dangerous gas if mixed with other products”;
(b)liquid preparations containing less than 2 per cent of available chlorine; or
(c)other preparations containing 4 per cent or less of available chlorine.
Dichloromethane (methylene chloride) except—
(a)in preparations in pressurised spray packs labelled as degreasers, decarbonisers or paint strippers and containing 10 per cent or less of dichloromethane;
(b)in other preparations in pressurised spray packs; or
(c)in paints and tinters containing 5 per cent or less of dichloromethane.
Dichlorophen for the treatment of animals.
Dichlorvos—
(a)when impregnated in plastic resin strip material containing 20 per cent or less of dichlorvos;
(b)in sustained release resin pellets containing 20 per cent or less of dichlorvos for the treatment of animals; or
(c)in pressurised spray packs containing 10 g or less of dichlorvos.
Diclobutrazol.
Dicloran.
Dicofol.
Diethanolamine (excluding its salts and derivatives) in preparations containing 20 per cent or less of diethanolamine except in preparations containing 5 per cent or less of diethanolamine.
Diethylene glycol (excluding its salts and derivatives) in preparations containing not less than 10 mg/kg of denatonium benzoate as a bittering agent except—
(a)in paints or paint tinters;
(b)in toothpastes or mouthwashes containing more than 0.25 per cent of diethylene glycol; or
(c)in other preparations containing 2.5 per cent or less of diethylene glycol.
Diethylene glycol monobutyl ether except in preparations containing 10 per cent or less of diethylene glycol monobutyl ether.
Diethyltoluamide (deet) except—
(a)in medicines for human therapeutic use containing 20 per cent or less of diethyltoluamide, when compliant with the labelling requirements under the Act;
(b)in preparations for human use, other than medicines, containing 20 per cent or less of diethyltoluamide, when labelled with the warning statement “WARNING — May be dangerous, particularly to children, if you use large amounts on the skin, clothes or bedding or on large areas of the body, especially if you keep using it for a long time.”; or
(c)in preparations other than for human use containing 20 per cent or less of diethyltoluamide.
Difenoconazole.
Diflubenzuron.
Dimethicodiethylbenzalmalonate except when included in preparations containing 10 per cent or less of dimethicodiethylbenzalmalonate.
Dimethirimol.
Dimethomorph except in preparations containing 10 per cent or less of dimethomorph.
Dimethylacetamide in preparations containing 20 per cent or less of dimethylacetamide.
Dimethylformamide in preparations containing 10 per cent or less of dimethylformamide except in silicone rubber mastic containing 2 per cent or less of dimethylformamide.
3,7-dimethyl-2,6-octadienal and its isomers in cosmetic and household cleaning preparations except in preparations containing 5 per cent or less of 3,7-dimethyl-2,6,-octadienal isomers.
Diniconazole.
Dinotefuran except in preparations containing 1 per cent or less of dinotefuran.
Di-n-propyl isocinchomeronate except in preparations containing 25 per cent or less of di-n-propyl isocinchomeronate.
Diphenamid.
Direct red 254 in preparations containing 30 per cent or less of direct red 254 calculated as free acid.
Dithiopyr.
N-(n-dodecyl)-2-pyrrolidone in preparations containing 50 per cent or less of n-(n-dodecyl)-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any 2 or more of N-(N-dodecyl)-2-pyrrolidone, N-methyl-2-pyrrolidone or N-(N-octyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.
Doramectin for internal use for the treatment of animals, in preparations containing 2 per cent or less of doramectin.
Emamectin in preparations containing 2 per cent or less of emamectin.
Emodepside in preparations—
(a)containing 2.5 per cent or less of emodepside for the external treatment of animals; or
(b)containing 30 mg or less of emodepside per dosage unit for the oral treatment of animals.
Epoxiconazole.
Epoxy resins, liquid.
Eprinomectin in preparations containing 0.5 per cent or less of eprinomectin.
Esbiothrin in preparations containing 10 per cent or less of esbiothrin except in pressurised spray packs containing 1 per cent or less of esbiothrin.
Esfenvalerate in preparations containing 0.1 per cent or less of esfenvalerate.
Estradiol in implant preparations for growth promotion in animals.
1,2-ethanediamine polymerwith (chloromethyl) oxirane and n-Methylmethanamine.
Ether in preparations containing more than 10 per cent of ether for use in internal combustion engines.
Ethofumesate.
Ethoxyquin except in preparations containing 10 per cent or less of ethoxyquin.
Ethoxysulfuron.
Ethylene glycol (excluding its salts and derivatives) in preparations containing not less than 10 mg/kg of denatonium benzoate as a bittering agent except—
(a)in paints or paint tinters;
(b)in toothpastes or mouthwashes containing more than 0.25 per cent of ethylene glycol; or
(c)in other preparations containing 2.5 per cent or less of ethylene glycol.
Ethyl methacrylate (excluding its derivatives) for cosmetic use except in preparations containing 1 per cent or less of ethyl methacrylate as residual monomer in a polymer.
Etridiazole.
Eugenol for topical use in the mouth in a pack containing 5 ml or less of eugenol except in preparations containing 25 per cent or less of eugenol.
Extract of lemon eucalyptus, being acid modified oil of lemon eucalyptus (Corymbia citriodora), except in preparations containing 40 per cent or less of extract of lemon eucalyptus.
Fenarimol.
Fenbendazole for the treatment of animals.
Fenbuconazole.
Fenchlorazole-ethyl.
Fennel oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and compliant with the requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 5 per cent or less of methyl chavicol.
Fenoprop.
Fenoxaprop-ethyl.
Fenoxaprop-p-ethyl.
Fenpyrazamine except in preparations containing 40 per cent or less of fenpyrazamine.
Fenson.
Fenthion—
(a)in preparations containing 25 per cent or less of fenthion when packed in single-use containers having a capacity of 2 ml or less; or
(b)in preparations containing 10 per cent or less of fenthion.
Fipronil in preparations containing 10 per cent or less of fipronil except in preparations containing 0.05 per cent or less of fipronil.
Flamprop-methyl.
Flamprop-m-methyl.
Flazasulfuron.
Florasulam.
Fluazuron.
Flubendazole for the treatment of animals.
Flubendiamide.
Fluchloralin.
Fludioxonil except in preparations containing 10 per cent or less of fludioxonil.
Flumethrin—
(a)when impregnated in plastic resin strip material containing 3 per cent or less of flumethrin; or
(b)in oil based preparations containing 1 per cent or less of flumethrin.
Flumiclorac pentyl.
Fluopyram except in preparations containing 50 per cent or less of fluopyram.
Fluorides in preparations containing 3 per cent or less of fluoride ion except—
(a)in preparations for human use; or
(b)in preparations containing 15 mg/kg or less of fluoride ion.
Fluralaner.
Fluvalinate in aqueous preparations containing 25 per cent or less of fluvalinate.
Fluxapyroxad.
Foramsulfuron.
Formic acid (excluding its salts and derivatives) except in preparations containing 0.5 per cent or less of formic acid.
Fospirate when impregnated in plastic resin strip material containing 20 per cent or less of fospirate.
Furalaxyl.
Furathiocarb in microencapsulated suspensions containing 50 per cent or less of furathiocarb.
Gamma-cyhalothrin in aqueous preparations containing 15 per cent or less of microencapsulated gamma-cyhalothrin.
Glufosinate-ammonium.
Glutaral in preparations containing 5 per cent or less of glutaral except—
(a)when included in Schedule 2; or
(b)in preparations containing 0.5 per cent or less of glutaral when labelled with the statements “IRRITANT” and “Avoid contact with eyes.”.
Glyphosate.
Halosulfuron-methyl.
Hexaconazole except in preparations containing 5 per cent or less of hexaconazole.
Hexazinone in preparations containing 25 per cent or less of hexazinone.
Hydramethylnon in solid baits containing 2 per cent or less of hydramethylnon in welded plastic labyrinths.
Hydrocarbons, liquid, including kerosene, diesel (distillate), mineral turpentine, white petroleum spirit, toluene, xylene and light mineral and paraffin oils (excluding its derivatives), except—
(a)toluene and xylene when included in Schedule 6;
(b)benzene and liquid aromatic hydrocarbons when included in Schedule 7;
(c)food grade and pharmaceutical grade white mineral oils;
(d)in solid or semi-solid preparations;
(e)in preparations containing 25 per cent or less of designated solvents;
(f)in preparations packed in pressurised spray packs;
(g)in adhesives packed in containers each containing 50 g or less of adhesive;
(h)in writing correction fluids and thinners for writing correction fluids packed in containers having a capacity of 20 ml or less; or
(i)in other preparations when packed in containers with a capacity of 2 ml or less.
Hydrochloric acid (excluding its salts and derivatives) in preparations containing 10 per cent or less of hydrochloric acid (HCl) except—
(a)in preparations containing 0.5 per cent or less of hydrochloric acid (HCl); or
(b)for therapeutic use.
Hydrofluoric acid (excluding its salts and derivatives) and admixtures that generate hydrofluoric acid, in preparations containing 0.1 per cent or less of hydrogen fluoride.
Hydrogen peroxide (excluding its salts and derivatives)—
(a)in hair dye preparations containing 12 per cent or less of hydrogen peroxide except in hair dyes containing 6 per cent or less of hydrogen peroxide; or
(b)in other preparations containing 6 per cent (20 volume) or less of hydrogen peroxide except in preparations containing 3 per cent (10 volume) or less of hydrogen peroxide.
Hydrosilicofluoric acid (excluding its salts and derivatives) in preparations containing 0.1 per cent or less of hydrosilicofluoric acid (H₂SiF₆).
2-hydroxyethyl methacrylate except when included in dental restorative preparations for therapeutic use or in nail preparations when labelled “avoid contact with skin”.
2-hydroxypropyl methacrylate in nail preparations except when labelled “avoid contact with skin”.
Imazalil.
Imazamox except in preparations containing 25 per cent or less of imazamox.
Imazapic except in preparations containing 25 per cent or less of imazapic.
Imazapyr except in preparations containing 25 per cent or less of imazapyr.
Imazethapyr except in preparations containing 25 per cent or less of imazethapyr.
Imidacloprid in preparations containing 20 per cent or less of imidacloprid except in preparations containing 5 per cent or less of imidacloprid.
Imiprothrin in preparations containing 50 per cent or less of imiprothrin except in preparations containing 10 per cent or less of imiprothrin.
Indoxacarb (includes the R and S enantiomers) in preparations containing 1 per cent or less of indoxacarb.
3-iodo-2-propynyl butyl carbamate (iodocarb) in preparations containing 10 per cent or less of 3-iodo-2-propynyl butyl carbamate except—
(a)in aqueous preparations not for cosmetic use containing 10 per cent or less 3-iodo-2-propynyl butyl carbamate; or
(b)in cosmetic preparations (other than aerosolised preparations) containing 0.1 per cent or less of 3-iodo-2-propynyl butyl carbamate.
Iodosulfuron-methyl-sodium.
Ipconazole in preparations containing 2 per cent or less of ipconazole.
Iron compounds—
(a)for the treatment of animals (excluding up to 1 per cent of iron oxides when present as an excipient)—
(i)in preparations for injection containing 20 per cent or less of iron except in preparations containing 0.1 per cent or less of iron; or
(ii)in other preparations containing 4 per cent or less of iron except—
(A)in liquid or gel preparations containing 0.1 per cent or less of iron; or
(B)in animal feeds or feed premixes; or
(b)in garden preparations except in preparations containing 4 per cent or less of iron.
Isoeugenol in preparations not intended for skin contact containing 25 per cent or less of isoeugenol except in preparations containing 10 per cent or less of isoeugenol.
Isophorone.
Isoxaben.
Isoxaflutole.
Ivermectin for use in animals—
(a)in preparations for the prophylaxis of heartworm in cats and dogs;
(b)in intraruminal implants containing 160 mg or less of ivermectin;
(c)in preparations containing 3.5 per cent or less of ivermectin when packed in child-resistant packaging or in packaging approved by the relevant registration authority; or
(d)in other preparations containing 2 per cent or less of ivermectin.
Kitasamycin in animal feed premixes for growth promotion containing 2 per cent or less of antibiotic substances.
Lambda-cyhalothrin—
(a)in aqueous preparations containing 1 per cent or less of lambda- cyhalothrin; or
(b)in aqueous preparations containing 10 per cent or less of microencapsulated lambda-cyhalothrin.
Lasiodiplodia pseudotheobromae except when used as a herbicide in capsule preparations at a concentration of 16 CFU or less per capsule.
Lead compounds in preparations for use as hair cosmetics.
Lemon oil except—
(a)when steam distilled or rectified;
(b)in preparations for internal use;
(c)in preparations containing 0.05 per cent or less of lemon oil;
(d)in soaps or bath or shower gels that are washed off the skin;
(e)in medicines for human therapeutic use, when compliant with the labelling requirements under the Act; or
(f)in other preparations when packed in containers labelled with the statement “Application to the skin may increase sensitivity to sunlight”.
Lemongrass oil in cosmetic and household cleaning preparations except in preparations containing 5 per cent or less of 3,7-dimethyl-2,6-octadienal.
Levamisole in preparations containing 15 per cent or less of levamisole for the treatment of animals except—
(a)when included in Schedule 4; or
(b)in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.
Lidocaine in aqueous gel preparations containing 4.5 per cent or less of lidocaine, for the dermal spray-on administration to post-surgical wounds associated with ‘mulesing’ of sheep; tail docking and castration of lambs; or castration and disbudding/dehorning in calves.
Lime oil except—
(a)when steam distilled or rectified;
(b)in preparations for internal use;
(c)in preparations containing 0.5 per cent or less of lime oil;
(d)in soaps or bath or shower gels that are washed off the skin;
(e)in medicines for human therapeutic use, when compliant with the labelling requirements under the Act; or
(f)in other preparations when packed in containers labelled with the statement—“Application to the skin may increase sensitivity to sunlight”.
Lindane in preparations containing 10 per cent or less of lindane except when included in schedules 2 or 4.
Lotilaner.
Lufenuron except—
(a)in divided preparations each containing 500 mg or less of lufenuron for the treatment of animals; or
(b)in single use syringes each containing 500 mg or less of lufenuron for the treatment of animals.
Macrophomina phaseolina except when used as a herbicide in capsule preparations at a concentration of 16 CFU or less per capsule.
Maduramicin in animal feed premixes containing 1 per cent or less of antibiotic substances.
Magnesium chlorate except in preparations containing 10 per cent or less of magnesium chlorate.
Malachite green in preparations for veterinary use containing 10 per cent or less of malachite green.
Malathion in preparations containing 10 per cent or less of malathion except—
(a)for human therapeutic use; or
(b)in dust preparations containing 2 per cent or less of malathion.
Mancozeb.
Mandestrobin except in preparations containing 25 per cent or less of mandestrobin.
Mandipropamid.
Marjoram oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 50 per cent or less of marjoram oil.
Mcpa—
(a)in preparations containing 25 per cent or less of mcpa (acid); or
(b)in preparations containing 50 per cent or less of the salts and esters of mcpa.
Mebendazole for the treatment of animals—
(a)in divided preparations each containing 300 mg or less of mebendazole per dosage unit; or
(b)in undivided preparations containing 25 per cent or less of mebendazole.
Meclofenamic acid for the treatment of animals.
Mecoprop in preparations containing 2 per cent or less of mecoprop.
Mefenpyr-diethyl.
Mefentrifluconazole except in preparations containing 7.5 per cent or less of mefentrifluconazole.
Mepiquat.
Mercaptamine in cosmetic preparations containing 6 per cent or less of mercaptamine except in preparations containing 1 per cent or less of mercaptamine.
Mercaptoacetic acid and its salts, but excluding its derivatives, in cosmetic preparations containing 20 per cent or less of mercaptoacetic acid or its salts (as mercapturic acid), except in preparations containing 5 per cent or less of mercaptoacetic acid or its salts (as mercapturic acid).
Mesotrione.
Metaflumizone.
Metalaxyl in preparations containing 35 per cent or less of metalaxyl.
Metaldehyde in preparations containing 2 per cent or less of metaldehyde.
Metazachlor.
Methabenzthiazuron.
Methanol (excluding its derivatives) in preparations containing 10 per cent or less of methanol except in preparations containing 2 per cent or less of methanol.
Methenamine in cosmetic preparations, except in preparations containing 0.15 per cent or less of methenamine.
Methiocarb in pelleted preparations containing 2 per cent or less of methiocarb.
Methiozolin.
Methoxychlor.
Methylated spirit (being ethanol denatured with denatonium benzoate, methyl isobutyl ketone and fluorescein) except—
(a)when included in preparations or admixtures; or
(b)when packed in containers having a capacity of more than 5 litres.
Methylated spirit when packed and labelled as a ‘biofuel’ suitable for use in ‘spirit burners’.
Methylene blue in preparations for veterinary use containing 50 per cent or less of methylene blue.
Methyl ethyl ketone except in preparations containing 25 per cent or less of designated solvents.
Methyl ethyl ketone peroxide.
Methyl isoamyl ketone except in preparations containing 25 per cent or less of designated solvents.
Methyl isobutyl ketone except in preparations containing 25 per cent or less of designated solvents.
N-methyl-2-pyrrolidone—
(a)when packed in single use containers having a capacity of 2 ml or less; or
(b)in preparations containing 50 per cent or less of N-methyl-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any 2 or more of N-methyl-2-pyrrolidone, N-(N-octyl)-2-pyrrolidone or N-(N-dodecyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.
Methyl salicylate in preparations containing 25 per cent or less of methyl salicylate except—
(a)in preparations for therapeutic use; or
(b)in preparations containing 5 per cent or less of methyl salicylate.
2-methylthio-4-(2-methylprop-2-yl) amino-6-cyclopropylamino-5-triazine.
Metiram.
Metofluthrin—
(a)in impregnated fabric mosquito repellent preparations for use in a vaporiser containing 15 mg or less of metofluthrin per disk; or
(b)when impregnated into a polyethylene slow release matrix containing 250 mg or less of metofluthrin.
Metolachlor.
Metrafenone in preparations containing 50 per cent or less of metrafenone.
Milbemectin in preparations containing 1 per cent or less of milbemectin.
Milbemycin oxime—
(a)for the prophylaxis of heartworm in dogs and cats; or
(b)for the treatment and prevention of flea infestations, control of ticks, gastrointestinal nematodes and heartworm in dogs, when combined with afoxolaner, in oral divided preparations each containing 150 mg or less of afoxolaner per dosage unit.
Monensin in intraruminal implants for cattle, each containing 35 g or less of monensin.
Monepantel.
Monoethanolamine (excluding its salts and derivatives) in preparations containing 20 per cent or less of monoethanolamine except—
(a)when included in Schedule 4; or
(b)in preparations containing 5 per cent or less of monoethanolamine.
Morantel in preparations containing 25 per cent or less of morantel except in preparations containing 10 per cent or less of morantel.
Moxidectin—
(a)in preparations for external use for the treatment of animals other than cats and dogs, containing 0.5 per cent or less of moxidectin;
(b)in preparations for external use for the treatment of cats and dogs, containing 2.5 per cent or less of moxidectin packed in single dose tubes with a volume of 1 ml or less; or
(c)for internal use for the treatment of animals—
(i)in divided preparations for dogs, containing 250 μg or less of moxidectin per dosage unit in a pack containing 6 or less dosage units; or
(ii)in other preparations containing 2 per cent or less of moxidectin.
Myclobutanil.
NAA except in preparations containing 25 per cent or less of NAA.
Naled when impregnated in plastic resin strip material containing 20 per cent or less of naled.
Naptalam.
Neoscytalidium novaehollandiae except when used as a herbicide in capsule preparations at a concentration of 16 cfu or less per capsule.
Netobimin for the treatment of animals, in preparations containing 12.5 per cent or less of netobimin.
Nitric acid (excluding its salts and derivatives) in preparations containing 10 per cent or less of nitric acid (HNO₃) except in preparations containing 0.5 per cent or less of nitric acid.
Nitroscanate for the treatment of animals.
Nonanoic acid—
(a)when used in a pesticide; or
(b)in other preparations except in preparations containing 10 per cent or less of nonanoic acid.
Nonoxinol 9 in preparations containing 25 per cent or less of nonoxinol 9 except—
(a)when labelled with the statements “ IRRITANT” and “Avoid contact with eyes”;
(b)in preparations containing 12.5 per cent or less of nonoxinol 9; or
(c)in preparations for human use.
Norbormide.
Nutmeg oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 50 per cent or less of nutmeg oil.
N-octyl bicycloheptene dicarboximide except in preparations containing 10 per cent or less of n-octyl bicycloheptene dicarboximide.
N-(n-octyl)-2-pyrrolidone in preparations containing 50 per cent or less of—
(a)N-(N-octyl)-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any 2 or more of N-(N-octyl)-2-pyrrolidone, N-methyl-2-pyrrolidone; or
(b)N-(N-dodecyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.
Oleandomycin in animal feed premixes for growth promotion.
Omethoate in pressurised spray packs containing 0.2 per cent or less of omethoate.
Orange oil (bitter) except—
(a)when steam distilled or rectified;
(b)in preparations for internal use;
(c)in preparations containing 1.4 per cent or less of orange oil (bitter);
(d)in soaps or bath or shower gels that are washed off the skin;
(e)in medicines for human therapeutic use, when compliant with the labelling requirements under the Act; or
(f)in other preparations when packed in containers labelled with the statement “Application to the skin may increase sensitivity to sunlight”.
Oxadiargyl.
Oxadixyl.
Oxantel embonate for the treatment of animals.
Oxfendazole for the treatment of animals.
Oxibendazole for the treatment of animals.
Oxycarboxin.
Oxytetracycline in preparations—
(a)for topical application to animals for ocular use only; or
(b)containing 40 per cent or less of oxytetracycline per dose, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Oxythioquinox.
Paclobutrazol.
Penconazole.
Pendimethalin.
Penflufen.
Penthiopyrad except in preparations containing 20 per cent or less of penthiopyrad.
Peracetic acid in concentrations of 10 per cent or less of peracetic acid.
Permethrin (excluding preparations for human therapeutic use)—
(a)in preparations containing 25 per cent or less of permethrin; or
(b)in preparations for external use, for the treatment of dogs, containing 50 per cent or less of permethrin when packed in single use containers having a capacity of 4 ml or less,
except in preparations containing 2 per cent or less of permethrin.
Petrol except preparations containing 25 per cent or less of petrol.
Phenazone for the external treatment of animals.
Phenisopham.
Phenol, including cresols and xylenols and any other homologue of phenol boiling below 220°C, when in animal feed additives containing 15 per cent or less of such substances, except in preparations containing 1 per cent or less of phenol and in preparations containing 3 per cent or less of cresols and xylenols and other homologues of phenol.
Phenyl methyl ketone except in preparations containing 25 per cent or less of designated solvents.
O-phenylphenol except in preparations containing 5 per cent or less of o-phenylphenol.
Phosphonic acid (excluding its salts and derivatives) except in preparations containing 10 per cent or less of phosphonic acid (H₃PO₃).
Phosphoric acid (excluding its salts and derivatives) in preparations containing 35 per cent or less of phosphoric acid (H₃PO₄) except—
(a)in preparations containing 15 per cent or less of phosphoric acid (H3PO4);
(b)in solid or semi-solid preparations; or
(c)in professional dental kits.
O-phthalaldehyde in preparations containing 1 per cent or less of o-phthalaldehyde.
Picaridin except in preparations containing 20 per cent or less of picaridin.
Pine oils in preparations containing 25 per cent or less of pine oils when packed and labelled as a herbicide.
Pinoxaden in preparations containing 10 per cent or less of pinoxaden.
Piperazine for animal use.
Pirimicarb in preparations containing 0.5 per cent or less of pirimicarb.
Polixetonium salts in preparations containing 60 per cent or less of polixetonium salts except in preparations containing 1 per cent or less of polixetonium salts.
Polyethanoxy (15) tallow amine.
Poly(oxy-1,2-ethanediyl), α-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]- α-hydroxy-,mono-c_13-15-alkyl ethers.
Potassium chlorate except—
(a)when included in Schedule 2; or
(b)in preparations containing 10 per cent or less of potassium chlorate.
Potassium hydroxide (excluding its salts and derivatives) in preparations containing 5 per cent or less of potassium hydroxide being—
(a)solid preparations, the pH of which in a 10 g/l aqueous solution is more than 11.5; or
(b)liquid or semi-solid preparations, the pH of which is more than 11.5 except in food additive preparations for domestic use.
Potassium metabisulphite when packed for domestic use except in preparations containing 10 per cent or less of potassium metabisulphite.
Potassium nitrite in preparations containing 1 per cent or less of potassium nitrite except—
(a)in preparations containing 0.5 per cent or less of potassium nitrite;
(b)when present as an excipient in preparations for therapeutic use; or
(c)in aerosols.
Potassium peroxomonosulfate triple salt in preparations containing 5 per cent or less of potassium peroxomonosulfate triple salt being—
(a)solid preparations, the pH of which in a 10 g/l aqueous solution is less than 2.5; or
(b)liquid or semi-solid preparations, the pH of which is less than 2.5.
Potassium sulfide in preparations for metal treatment in containers each containing 50 g or less of potassium sulfide.
Prallethrin (cis:trans=20:80) in preparations containing 10 per cent or less of prallethrin except in insecticidal mats containing 1 per cent or less of prallethrin.
Profoxydim except in preparations containing 20 per cent or less of profoxydim.
Progesterone—
(a)in implant preparations or controlled release pessaries for synchronisation of oestrus in cattle, sheep or goats; or
(b)in implant preparations for growth promotion in cattle.
Prohexadione calcium.
Prometryn.
Propamocarb.
Propanil.
Propaquizafop.
Propiconazole in preparations containing 20 per cent or less of propiconazole.
Propionic acid (excluding its salts and derivatives) in preparations containing 80 per cent or less of propionic acid, except—
(a)in preparations containing 30 per cent or less of propionic acid; or
(b)for therapeutic use.
Propoxur—
(a)when impregnated in plastic resin strip material containing 10 per cent or less of propoxur;
(b)in dust preparations containing 3 per cent or less of propoxur;
(c)in granular sugar-based fly baits containing 1 per cent or less of propoxur, a dark colouring agent and a separate bittering agent;
(d)in pressurised spray packs containing 2 per cent or less of propoxur; or
(e)in printed paper sheets for pest control containing 0.5 per cent or less of propoxur and in any case not more than 100 mg of propoxur per sheet.
N-propyl alcohol in preparations containing 10 per cent or less of n-propyl alcohol except—
(a)in preparations containing 5 per cent or less of n-propyl alcohol; or
(b)in preparations for cosmetic or therapeutic use other than in spray form.
Propyzamide.
Prothioconazole-deschloro except in preparations containing 0.5 per cent or less of prothioconazole-deschloro.
Prothioconazole-triazolidinethione except in preparations containing 0.5 per cent or less of prothioconazole-triazolidinethione.
Pymetrozine.
Pyraclostrobin.
Pyraflufen-ethyl.
Pyrasulfotole.
Pyrethrins, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of chrysanthemic or pyrethric acids except—
(a)in preparations for human therapeutic use; or
(b)in preparations containing 10 per cent or less of such substances.
Pyridaben in preparations containing 25 per cent or less of pyridaben.
Pyrifenox.
Pyrithiobac sodium.
Pyrithione zinc in paints containing 0.5 per cent or less of pyrithione zinc calculated on the non-volatile content of the paint except in paints containing 0.1 per cent or less of pyrithione zinc calculated on the non-volatile content of the paint.
Pyriofenone in preparations containing 30 per cent or less of pyriofenone.
Quaternary ammonium compounds in preparations containing 20 per cent or less of quaternary ammonium compounds except—
(a)when separately specified in the schedules to these Regulations;
(b)dialkyl or dialkoyl quaternary ammonium compounds where the alkyl or alkoyl groups are derived from tallow or hydrogenated tallow or similar chain length (C16/C18) sources; or
(c)in preparations containing 5 per cent or less of such quaternary ammonium compounds.
Quinclorac.
Quinine in preparations for veterinary use containing 1 per cent or less of quinine.
Quintozene.
Quizalofop-p-ethyl in aqueous preparations containing 40 per cent or less of quizalofop-p-ethyl.
Ractopamine in animal feed premixes containing 10 per cent or less of ractopamine.
Resmethrin in preparations containing 10 per cent or less of resmethrin.
Rimsulfuron.
Robenidine except in preparations containing 20 per cent or less of robenidine.
Rosin when packaged for use as a soldering flux or in flux-cored solder.
Saflufenacil in water dispersible granules or a water-based suspension concentrate.
Salicylanilide.
Sarolaner for veterinary use in divided preparations each containing 120 mg or less of sarolaner per dosage unit.
Sedaxane.
Selamectin except in preparations containing 12 per cent or less of selamectin.
Sethoxydim.
Siduron.
Silicofluorides in preparations containing 3 per cent or less of fluoride ion except—
(a)barium silicofluoride when separately specified in this schedule; or
(b)in preparations containing 15 mg/kg or less of fluoride ion.
Sinbioallethrin in preparations containing 10 per cent or less of sinbioallethrin except in preparations containing 1 per cent or less of sinbioallethrin.
Sodium chlorate except in preparations containing 10 per cent or less of sodium chlorate.
Sodium diacetate except in preparations containing 60 per cent or less of sodium diacetate.
Sodium dodecylbenzene sulfonate except in preparations containing 30 per cent or less of sodium dodecylbenzene sulfonate.
Sodium hydrogen sulfate except in preparations containing 10 per cent or less of sodium hydrogen sulfate.
Sodium hydrosulfite when packed for domestic use except in preparations containing 10 per cent or less of sodium hydrosulfite.
Sodium hydroxide (excluding its salts and derivatives) in preparations containing 5 per cent or less of sodium hydroxide being—
(a)solid preparations, the pH of which in a 10 g/l aqueous solution is more than 11.5; or
(b)liquid or semi-solid preparations, the pH of which is more than 11.5 except in food additive preparations for domestic use.
Sodium laureth-6 carboxylate except in preparations containing 1 per cent or less of sodium laureth-6 carboxylate.
Sodium metabisulphite when packed for domestic use except in preparations containing 10 per cent or less of sodium metabisulphite.
Sodium nitrite in preparations containing 1 per cent or less of sodium nitrite except—
(a)in preparations containing 0.5 per cent or less of sodium nitrite;
(b)when present as an excipient in preparations for therapeutic use; or
(c)in aerosols.
Sodium percarbonate (CAS No. 15630-89-4) in preparations containing 35 per cent or less of sodium percarbonate except in preparations containing 15 per cent or less of sodium percarbonate.
Sodium polystyrene sulphonate in preparations for cosmetic use except in preparations containing 10 per cent or less of sodium polystyrene sulphonate.
Sodium stannate except in preparations for cosmetic use containing 1 per cent or less of sodium stannate.
Sodium sulfide in preparations for metal treatment in containers each containing 50 g or less of sodium sulfide.
Spinetoram.
Spinosad except in aqueous suspensions containing 25 per cent or less of spinosad.
Star anise oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 50 per cent or less of star anise oil.
Styrene (excluding its derivatives).
Sulfacetamide when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Sulfadiazine when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Sulfadimidine when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Sulfamerazine when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Sulfamic acid (excluding its salts and derivatives) in preparations containing 10 per cent or less of sulfamic acid (H₃No₃S).
Sulfathiazole when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Sulfometuron-methyl.
Sulfoxaflor in preparations containing 25 per cent or less of sulfoxaflor.
Symphytum spp. (comfrey) for dermal therapeutic or dermal cosmetic use.
2,3,6-tba.
Tde (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane) in preparations containing 10 per cent or less of tde.
Tebuconazole.
Tebufenozide.
Tefluthrin in preparations containing 2 per cent or less of tefluthrin.
Temephos—
(a)in liquid preparations containing 10 per cent or less of temephos;
(b)in powders containing 2 per cent or less of temephos; or
(c)in preparations containing 40 per cent or less of temephos when packed in single use containers having a capacity of 2 ml or less.
Tepraloxydim.
Terbutryn.
Tetrachloroethylene in preparations containing 5 per cent or less of tetrachloroethylene except—
(a)when included in Schedule 2;
(b)in preparations for the treatment of animals; or
(c)when absorbed into an inert solid.
Tetrachlorvinphos except in animal feeds containing 0.2 per cent or less of tetrachlorvinphos.
Tetraconazole in preparations containing 20 per cent or less of tetraconazole.
Tetracycline in preparations—
(a)for topical application to animals for ocular use only; or
(b)containing 40 per cent or less of tetracycline when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.
Tetramethrin [(R, cis): (R, trans) = 20:80] except in pressurised spray packs.
Tetraniliprole except in preparations containing 20 per cent or less tetraniliprole.
Thiabendazole—
(a)for the treatment of animals; or
(b)when packed and labelled for use as a fungicide except in preparations containing 50 per cent or less of thiabendazole.
Thiamethoxam in preparations containing 60 per cent or less of thiamethoxam.
Thiazopyr.
Thifensulfuron.
Thiobencarb.
Thiodicarb in pelleted preparations containing 1.5 per cent or less of thiodicarb.
Thiophanate-methyl in preparations containing 25 per cent or less of thiophanate-methyl.
Thyme oil except—
(a)in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and compliant with the labelling requirements under the Act;
(b)in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert, and labelled with the warning “KEEP OUT OF REACH OF CHILDREN”; or
(c)in preparations containing 50 per cent or less of thyme oil.
Tiocarbazil.
Tolclofos-methyl.
Toltrazuril.
Topramezone.
Tralkoxydim.
Trenbolone in implant preparations for growth promotion in animals.
Triadimefon in wettable powders containing 25 per cent or less of triadimefon.
Triadimenol.
Tri-allate.
Tribenuron-methyl.
Trichloroacetic acid, alkali salts of.
1,1,1-trichloroethane except—
(a)in preparations packed in pressurised spray packs;
(b)in preparations containing 25 per cent or less of designated solvents;
(c)in preparations, other than writing correction fluids or thinners for writing correction fluidsin containers having a capacity of 50 ml or less; or
(d)in writing correction fluids or thinners for writing correction fluids, in containers having a capacity of 50 ml or less labelled with—
(i)the word “Trichloroethane” written in letters not less than 1 mm in height and in distinct contrast to the background; and
(ii)the expression “WARNING — DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU” written in bold face sans serif capital letters not less than 1 mm in height and in distinct contrast to the background.
Tridiphane.
Trietazine.
Trifloxystrobin.
Trifludimoxazin except in preparations containing 12.5 per cent or less.
Triflumizole.
Triflumuron.
Triisopropanolamine lauryl ether sulfate except in preparations containing 30 per cent or less of triisopropanolamine lauryl ether sulfate when labelled with the statements “Avoid contact with eyes and skin” and “Wash hands after handling”.
Trinexapac-ethyl except—
(a)when packed in a sealed water-soluble measure pack; or
(b)in solid preparations containing 25 per cent or less of trinexapac-ethyl in packs of 50 g or less.
3,6,9-trioxaundecanedioic acid except in preparations containing 5 per cent or less of 3,6,9-trioxaundecanedioic acid, the pH of which is 3.5 or greater.
Triticonazole.
Trolamine (excluding its salts and derivatives) except—
(a)when in Schedule 4; or
(b)in preparations containing 5 per cent or less of trolamine.
Turpentine oil except in preparations containing 25 per cent or less of turpentine oil.
Virginiamycin in animal feed additives containing 1 per cent or less of virginiamycin for the prevention of laminitis in horses when in a pack of 5 kg or less.
Vernolate.
Warfarin in rodent baits containing 0.1 per cent or less of warfarin.
Zineb.